DE3173933D1 - Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them - Google Patents

Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them

Info

Publication number
DE3173933D1
DE3173933D1 DE8181110457T DE3173933T DE3173933D1 DE 3173933 D1 DE3173933 D1 DE 3173933D1 DE 8181110457 T DE8181110457 T DE 8181110457T DE 3173933 T DE3173933 T DE 3173933T DE 3173933 D1 DE3173933 D1 DE 3173933D1
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical formulations
formulations containing
pyrazoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181110457T
Other languages
English (en)
Inventor
Frederick Charles Copp
Albert Gordon Caldwell
David Collard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3173933D1 publication Critical patent/DE3173933D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8181110457T 1980-12-16 1981-12-15 Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them Expired DE3173933D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8040172 1980-12-16
US25607281A 1981-04-21 1981-04-21

Publications (1)

Publication Number Publication Date
DE3173933D1 true DE3173933D1 (en) 1986-04-03

Family

ID=26277856

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19813149710 Withdrawn DE3149710A1 (de) 1980-12-16 1981-12-15 Heterocyclische verbindungen, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen
DE8181110457T Expired DE3173933D1 (en) 1980-12-16 1981-12-15 Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19813149710 Withdrawn DE3149710A1 (de) 1980-12-16 1981-12-15 Heterocyclische verbindungen, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen

Country Status (18)

Country Link
EP (1) EP0055418B1 (de)
AT (1) AT379803B (de)
AU (1) AU559488B2 (de)
CA (1) CA1180335A (de)
CH (1) CH654209A5 (de)
DE (2) DE3149710A1 (de)
DK (1) DK556381A (de)
ES (1) ES507975A0 (de)
FI (1) FI814024L (de)
FR (1) FR2496100B1 (de)
GR (1) GR76989B (de)
HU (1) HU187392B (de)
IE (1) IE51951B1 (de)
IL (1) IL64555A (de)
MC (1) MC1435A1 (de)
NL (1) NL8105652A (de)
NZ (1) NZ199288A (de)
SE (1) SE8107524L (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070376A1 (de) * 1981-07-13 1983-01-26 American Cyanamid Company Heterocyclische substituierte Amino-Pyrazoline
DK60684A (da) * 1983-02-11 1984-08-12 Wellcome Found Fremgangsmaade til fremstilling af 3-(n-substitueret amino)-2-pyrazoliner og mellemprodukter anvendelige ved udoevelse af fremgangsmaaden
GB8303782D0 (en) * 1983-02-11 1983-03-16 Wellcome Found Heterocyclic compounds
US4824859A (en) * 1983-05-21 1989-04-25 Fisons Plc. Pyrazoline compounds compositions and use
ATE49198T1 (de) * 1984-05-12 1990-01-15 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
FR2781147B1 (fr) 1998-07-20 2000-09-15 Oreal Compositions pour la teinture des fibres keratiniques contenant des derives de 3-amino pyrazolines a titre de coupleur, procede de teinture et kit de teinture
GB0603181D0 (en) * 2006-02-17 2006-03-29 Merck Sharp & Dohme Treatment of neurodegenerative and psychiatric diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT266761B (de) * 1964-05-27 1968-11-25 Geigy Ag J R Verfahren zum optischen Aufhellen von hochmolekularem organischem Material
FR2059449A1 (de) * 1969-02-26 1971-06-04 Synthelabo
AU537499B2 (en) * 1979-07-13 1984-06-28 Wellcome Foundation Limited, The Compositions for treating inflammatory conditions

Also Published As

Publication number Publication date
GR76989B (de) 1984-09-04
HU187392B (en) 1985-12-28
EP0055418A3 (en) 1982-08-18
CH654209A5 (de) 1986-02-14
AU7851081A (en) 1982-06-24
DE3149710A1 (de) 1982-08-05
AU559488B2 (en) 1987-03-12
EP0055418B1 (de) 1986-02-26
MC1435A1 (fr) 1982-12-06
ES8307224A1 (es) 1983-06-16
AT379803B (de) 1986-03-10
SE8107524L (sv) 1982-06-17
ES507975A0 (es) 1983-06-16
DK556381A (da) 1982-06-17
CA1180335A (en) 1985-01-02
FR2496100A1 (fr) 1982-06-18
IL64555A0 (en) 1982-03-31
NZ199288A (en) 1985-07-31
NL8105652A (nl) 1982-07-16
IE812944L (en) 1982-06-16
IE51951B1 (en) 1987-04-29
IL64555A (en) 1986-01-31
FR2496100B1 (fr) 1985-06-14
EP0055418A2 (de) 1982-07-07
ATA537281A (de) 1985-07-15
FI814024L (fi) 1982-06-17

Similar Documents

Publication Publication Date Title
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
IL63410A0 (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
ZA816213B (en) Solid medicament formulations containing nifidipine,and processes for their preparation
DE3171234D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical derivatives containing them
IL63405A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL63406A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
IL59410A0 (en) Pyrazole derivatives,pharmaceutical formulations containing these derivatives and processes for their preparation
DE3169095D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
DE3160987D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
DE3173933D1 (en) Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them
ZA812034B (en) Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use
ZA817787B (en) Indolinone derivatives,processes for their preparation and pharmaceutical compositions containing these
DE3165733D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3160986D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
IL63245A (en) 3-aminopropoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
IL62970A0 (en) Substituted phenoxy-aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
IL63174A0 (en) Dibenzindole derivatives,their preparation and pharmaceutical compositions containing them
ZA816046B (en) Pyrazine derivatives,processes for their preparation,and pharmaceutical compositions containing these
ZA812614B (en) Bis-hydroxybenzyl derivatives, processes for their preparation and pharmaceutical composition containing same
DE3167471D1 (en) Benzoquinolizines, processes for their preparation and pharmaceutical compositions
IL63369A (en) 13-oxa-prostaglandin derivatives,their preparation and pharmaceutical compositions containing them
IL62116A (en) Benzylidenimine derivatives,their preparation and pharmaceutical compositions containing them
DE3172167D1 (en) Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee